AlphaValue Corporate Services Fundamental Analysis FR
Back to
AlphaValue Corporate Services
This research has been commissioned and paid for by the company and is deemed to constitute an acceptable minor non-monetary benefit as defined in MiFID II

Crossject

CR
Bloomberg   ALCJ FP
Supergenerics  /  France  Web Site   |   Investors Relation
Getting closer to the market launch
Target
Upside 282%
Price (€) 2.75
Market Cap (€M) 61.6
Perf. 1W: -0.72%
Perf. 1M: -7.56%
Perf. 3M: -19.6%
Perf Ytd: -10.3%
10 day relative perf. to stoxx600: -12.0%
20 day relative perf. to stoxx600: -13.8%